{"title":"Antiviral activity of pyrazole derivatives bearing a hydroxyquinoline scaffold against SARS-CoV-2, HCoV-229E, MERS-CoV, and IBV propagation","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA04728A","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA04728A\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,27935-27947<br /><b>DOI</b>: 10.1039/D4RA04728A, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>Â  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Alaa R. I. Morsy, Sara H. Mahmoud, Noura M. Abou Shama, Walaa Arafa, Gehad A. Yousef, Ahmed. A. Khalil, Sayed K. Ramadan<br />Antiviral screening of hydroxyquinoline-pyrazoles against SARS-CoV-2, MERS-CoV, and HCoV-<a target=\"_blank\" href=\"http://xlink.rsc.org/?pdb=229E\">229E</a> revealed potent inhibition of SARS-CoV-2 at lower concentrations, highlighting their promise as therapeutic candidates against this highly pathogenic virus.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"9f58301b7f3e09d63175ca173a1523a437e37634cf4ebdb1813ee1c7e03e22da","category":"Environment"}